Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Raymond James analyst J.R. Weston upgraded Hess Midstream LP (NYSE:HESM) from Market Perform to Outperform and announced a $32 price target. Hess Midstream closed at $30.04 on Thursday. See how other analysts view this stock.
- Keefe, Bruyette & Woods analyst Christopher Mcgratty upgraded Valley National Bancorp (NASDAQ:VLY) from Market Perform to Outperform and maintained the price target of $17. Valley National Bancorp shares closed at $13.81 on Thursday. See how other analysts view this stock.
- B of A Securities analyst Rafe Jadrosich upgraded Allegion PLC (NYSE:ALLE) from Neutral to Buy and raised the price target from $164 to $200. Allegion closed at $176.52 on Wednesday. See how other analysts view this stock.
- WBB Securities analyst Karen Sterling upgraded Turn Therapeutics Inc (NASDAQ:TTRX) from Sell to Hold and maintained the price target of $10. Turn Therapeutics shares closed at $10.18 on Thursday. See how other analysts view this stock.
- B of A Securities analyst Tazeen Ahmad upgraded Pharvaris NV (NASDAQ:PHVS) from Neutral to Buy and maintained the price target of $44. Pharvaris closed at $30.68 on Thursday. See how other analysts view this stock.
Photo via Shutterstock
Recent Comments